22 research outputs found
Differential Kinobeads Profiling for Target Identification of Irreversible Kinase Inhibitors
Chemoproteomics
profiling of kinase inhibitors with kinobeads enables
the assessment of inhibitor potency and selectivity for endogenously
expressed protein kinases in cell lines and tissues. Using a small
panel of targeted covalent inhibitors, we demonstrate the importance
of measuring covalent target binding in live cells. We present a differential
kinobeads profiling strategy for covalent kinase inhibitors where
a compound is added either to live cells or to a cell extract that
enables the comprehensive assessment of inhibitor selectivity for
covalent and noncovalent targets. We found that Acalabrutinib, CC-292,
and Ibrutinib potently and covalently bind TEC family kinases, but
only Ibrutinib also potently binds to BLK. ZAK was identified as a
submicromolar affinity Ibrutinib off-target due to covalent modification
of Cys22. In contrast to Ibrutinib, 5Z-7-Oxozeaenol reacted with Cys150
next to the DFG loop, demonstrating an alternative route to covalent
inactivation of this kinase, e.g., to inhibit canonical TGF-β
dependent processes
High-Resolution Enabled TMT 8‑plexing
Isobaric mass tag-based quantitative proteomics strategies
such
as iTRAQ and TMT utilize reporter ions in the low-mass range of tandem
MS spectra for relative quantification. The number of samples that
can be compared in a single experiment (multiplexing) is limited by
the number of different reporter ions that can be generated by differential
stable isotope incorporation (<sup>15</sup>N, <sup>13</sup>C) across
the reporter and the mass balancing parts of the reagents. Here, we
demonstrate that a higher multiplexing rate can be achieved by utilizing
the 6 mDa mass difference between <sup>15</sup>N- and <sup>13</sup>C-containing reporter fragments, in combination with high-resolution
mass spectrometry. Two variants of the TMT127 and TMT129 reagents
are available; these are distinguished by the position and the nature
of the incorporated stable isotope in the reporter portions of the
labels (TMT127L, <sup>12</sup>C<sub>8</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; TMT127H, <sup>12</sup>C<sub>7</sub><sup>13</sup>C<sub>1</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>; TMT129L, <sup>12</sup>C<sub>6</sub><sup>13</sup>C<sub>2</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; and TMT129H, <sup>12</sup>C<sub>5</sub><sup>13</sup>C<sub>3</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>). We demonstrate that these variants
can be baseline-resolved in Orbitrap Elite higher-energy collision-induced
dissociation spectra recorded with a 96 ms transient enabling comparable
dynamic range, precision, and accuracy of quantification as 1 Da spaced
reporter ions. The increased multiplexing rate enabled determination
of inhibitor potencies in chemoproteomic kinase assays covering a
wider range of compound concentrations in a single experiment, compared
to conventional 6-plex TMT-based assays
Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes
Class I histone deacetylases (HDACs)
are attractive drug targets
in oncology and inflammation. However, the development of selective
inhibitors is complicated by the characteristic that the localization,
activity, and selectivity of class I HDACs are regulated by association
in megadalton repressor complexes. There is emerging evidence that
isoform and protein complex selectivity can be achieved by aminobenzamide
inhibitors. Here we present a chemoproteomics strategy for the determination
of time-dependent inhibitor binding to endogenous HDACs and HDAC complexes.
This approach enabled us to determine kinetic association and dissociation
rates for endogenously expressed repressor complexes. We found that
unlike hydroxamate type inhibitors, aminobenzamides exhibited slow
binding kinetics dependent on association within protein complexes.
These findings were in agreement with a delayed cellular response
on acetylation levels of distinct histone sites and the inability
of aminobenzamides to inhibit HDAC activity of a Sin3 complex isolated
from K562 cells
High-Resolution Enabled TMT 8‑plexing
Isobaric mass tag-based quantitative proteomics strategies
such
as iTRAQ and TMT utilize reporter ions in the low-mass range of tandem
MS spectra for relative quantification. The number of samples that
can be compared in a single experiment (multiplexing) is limited by
the number of different reporter ions that can be generated by differential
stable isotope incorporation (<sup>15</sup>N, <sup>13</sup>C) across
the reporter and the mass balancing parts of the reagents. Here, we
demonstrate that a higher multiplexing rate can be achieved by utilizing
the 6 mDa mass difference between <sup>15</sup>N- and <sup>13</sup>C-containing reporter fragments, in combination with high-resolution
mass spectrometry. Two variants of the TMT127 and TMT129 reagents
are available; these are distinguished by the position and the nature
of the incorporated stable isotope in the reporter portions of the
labels (TMT127L, <sup>12</sup>C<sub>8</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; TMT127H, <sup>12</sup>C<sub>7</sub><sup>13</sup>C<sub>1</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>; TMT129L, <sup>12</sup>C<sub>6</sub><sup>13</sup>C<sub>2</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; and TMT129H, <sup>12</sup>C<sub>5</sub><sup>13</sup>C<sub>3</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>). We demonstrate that these variants
can be baseline-resolved in Orbitrap Elite higher-energy collision-induced
dissociation spectra recorded with a 96 ms transient enabling comparable
dynamic range, precision, and accuracy of quantification as 1 Da spaced
reporter ions. The increased multiplexing rate enabled determination
of inhibitor potencies in chemoproteomic kinase assays covering a
wider range of compound concentrations in a single experiment, compared
to conventional 6-plex TMT-based assays
High-Resolution Enabled TMT 8‑plexing
Isobaric mass tag-based quantitative proteomics strategies
such
as iTRAQ and TMT utilize reporter ions in the low-mass range of tandem
MS spectra for relative quantification. The number of samples that
can be compared in a single experiment (multiplexing) is limited by
the number of different reporter ions that can be generated by differential
stable isotope incorporation (<sup>15</sup>N, <sup>13</sup>C) across
the reporter and the mass balancing parts of the reagents. Here, we
demonstrate that a higher multiplexing rate can be achieved by utilizing
the 6 mDa mass difference between <sup>15</sup>N- and <sup>13</sup>C-containing reporter fragments, in combination with high-resolution
mass spectrometry. Two variants of the TMT127 and TMT129 reagents
are available; these are distinguished by the position and the nature
of the incorporated stable isotope in the reporter portions of the
labels (TMT127L, <sup>12</sup>C<sub>8</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; TMT127H, <sup>12</sup>C<sub>7</sub><sup>13</sup>C<sub>1</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>; TMT129L, <sup>12</sup>C<sub>6</sub><sup>13</sup>C<sub>2</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; and TMT129H, <sup>12</sup>C<sub>5</sub><sup>13</sup>C<sub>3</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>). We demonstrate that these variants
can be baseline-resolved in Orbitrap Elite higher-energy collision-induced
dissociation spectra recorded with a 96 ms transient enabling comparable
dynamic range, precision, and accuracy of quantification as 1 Da spaced
reporter ions. The increased multiplexing rate enabled determination
of inhibitor potencies in chemoproteomic kinase assays covering a
wider range of compound concentrations in a single experiment, compared
to conventional 6-plex TMT-based assays
High-Resolution Enabled TMT 8‑plexing
Isobaric mass tag-based quantitative proteomics strategies
such
as iTRAQ and TMT utilize reporter ions in the low-mass range of tandem
MS spectra for relative quantification. The number of samples that
can be compared in a single experiment (multiplexing) is limited by
the number of different reporter ions that can be generated by differential
stable isotope incorporation (<sup>15</sup>N, <sup>13</sup>C) across
the reporter and the mass balancing parts of the reagents. Here, we
demonstrate that a higher multiplexing rate can be achieved by utilizing
the 6 mDa mass difference between <sup>15</sup>N- and <sup>13</sup>C-containing reporter fragments, in combination with high-resolution
mass spectrometry. Two variants of the TMT127 and TMT129 reagents
are available; these are distinguished by the position and the nature
of the incorporated stable isotope in the reporter portions of the
labels (TMT127L, <sup>12</sup>C<sub>8</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; TMT127H, <sup>12</sup>C<sub>7</sub><sup>13</sup>C<sub>1</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>; TMT129L, <sup>12</sup>C<sub>6</sub><sup>13</sup>C<sub>2</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; and TMT129H, <sup>12</sup>C<sub>5</sub><sup>13</sup>C<sub>3</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>). We demonstrate that these variants
can be baseline-resolved in Orbitrap Elite higher-energy collision-induced
dissociation spectra recorded with a 96 ms transient enabling comparable
dynamic range, precision, and accuracy of quantification as 1 Da spaced
reporter ions. The increased multiplexing rate enabled determination
of inhibitor potencies in chemoproteomic kinase assays covering a
wider range of compound concentrations in a single experiment, compared
to conventional 6-plex TMT-based assays
High-Resolution Enabled TMT 8‑plexing
Isobaric mass tag-based quantitative proteomics strategies
such
as iTRAQ and TMT utilize reporter ions in the low-mass range of tandem
MS spectra for relative quantification. The number of samples that
can be compared in a single experiment (multiplexing) is limited by
the number of different reporter ions that can be generated by differential
stable isotope incorporation (<sup>15</sup>N, <sup>13</sup>C) across
the reporter and the mass balancing parts of the reagents. Here, we
demonstrate that a higher multiplexing rate can be achieved by utilizing
the 6 mDa mass difference between <sup>15</sup>N- and <sup>13</sup>C-containing reporter fragments, in combination with high-resolution
mass spectrometry. Two variants of the TMT127 and TMT129 reagents
are available; these are distinguished by the position and the nature
of the incorporated stable isotope in the reporter portions of the
labels (TMT127L, <sup>12</sup>C<sub>8</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; TMT127H, <sup>12</sup>C<sub>7</sub><sup>13</sup>C<sub>1</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>; TMT129L, <sup>12</sup>C<sub>6</sub><sup>13</sup>C<sub>2</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; and TMT129H, <sup>12</sup>C<sub>5</sub><sup>13</sup>C<sub>3</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>). We demonstrate that these variants
can be baseline-resolved in Orbitrap Elite higher-energy collision-induced
dissociation spectra recorded with a 96 ms transient enabling comparable
dynamic range, precision, and accuracy of quantification as 1 Da spaced
reporter ions. The increased multiplexing rate enabled determination
of inhibitor potencies in chemoproteomic kinase assays covering a
wider range of compound concentrations in a single experiment, compared
to conventional 6-plex TMT-based assays
High-Resolution Enabled TMT 8‑plexing
Isobaric mass tag-based quantitative proteomics strategies
such
as iTRAQ and TMT utilize reporter ions in the low-mass range of tandem
MS spectra for relative quantification. The number of samples that
can be compared in a single experiment (multiplexing) is limited by
the number of different reporter ions that can be generated by differential
stable isotope incorporation (<sup>15</sup>N, <sup>13</sup>C) across
the reporter and the mass balancing parts of the reagents. Here, we
demonstrate that a higher multiplexing rate can be achieved by utilizing
the 6 mDa mass difference between <sup>15</sup>N- and <sup>13</sup>C-containing reporter fragments, in combination with high-resolution
mass spectrometry. Two variants of the TMT127 and TMT129 reagents
are available; these are distinguished by the position and the nature
of the incorporated stable isotope in the reporter portions of the
labels (TMT127L, <sup>12</sup>C<sub>8</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; TMT127H, <sup>12</sup>C<sub>7</sub><sup>13</sup>C<sub>1</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>; TMT129L, <sup>12</sup>C<sub>6</sub><sup>13</sup>C<sub>2</sub>H<sub>16</sub><sup>15</sup>N<sub>1</sub><sup>+</sup>; and TMT129H, <sup>12</sup>C<sub>5</sub><sup>13</sup>C<sub>3</sub>H<sub>16</sub><sup>14</sup>N<sub>1</sub><sup>+</sup>). We demonstrate that these variants
can be baseline-resolved in Orbitrap Elite higher-energy collision-induced
dissociation spectra recorded with a 96 ms transient enabling comparable
dynamic range, precision, and accuracy of quantification as 1 Da spaced
reporter ions. The increased multiplexing rate enabled determination
of inhibitor potencies in chemoproteomic kinase assays covering a
wider range of compound concentrations in a single experiment, compared
to conventional 6-plex TMT-based assays
Affinity Profiling of the Cellular Kinome for the Nucleotide Cofactors ATP, ADP, and GTP
Most kinase inhibitor drugs target the binding site of
the nucleotide
cosubstrate ATP. The high intracellular concentration of ATP can strongly
affect inhibitor potency and selectivity depending on the affinity
of the target kinase for ATP. Here we used a defined chemoproteomics
system based on competition-binding assays in cell extracts from Jurkat
and SK-MEL-28 cells with immobilized ATP mimetics (kinobeads). This
system enabled us to assess the affinities of more than 200 kinases
for the cellular nucleotide cofactors ATP, ADP, and GTP and the effects
of the divalent metal ions Mg<sup>2+</sup> and Mn<sup>2+</sup>. The
affinity values determined in this system were largely consistent
across the two cell lines, indicating no major dependence on kinase
expression levels. Kinase-ATP affinities range from low micromolar
to millimolar, which has profound consequences for the prediction
of cellular effects from inhibitor selectivity profiles. Only a small
number of kinases including CK2, MEK, and BRAF exhibited affinity
for GTP. This extensive and consistent data set of kinase-nucleotide
affinities, determined for native enzymes under defined experimental
conditions, will represent a useful resource for kinase drug discovery
Affinity Profiling of the Cellular Kinome for the Nucleotide Cofactors ATP, ADP, and GTP
Most kinase inhibitor drugs target the binding site of
the nucleotide
cosubstrate ATP. The high intracellular concentration of ATP can strongly
affect inhibitor potency and selectivity depending on the affinity
of the target kinase for ATP. Here we used a defined chemoproteomics
system based on competition-binding assays in cell extracts from Jurkat
and SK-MEL-28 cells with immobilized ATP mimetics (kinobeads). This
system enabled us to assess the affinities of more than 200 kinases
for the cellular nucleotide cofactors ATP, ADP, and GTP and the effects
of the divalent metal ions Mg<sup>2+</sup> and Mn<sup>2+</sup>. The
affinity values determined in this system were largely consistent
across the two cell lines, indicating no major dependence on kinase
expression levels. Kinase-ATP affinities range from low micromolar
to millimolar, which has profound consequences for the prediction
of cellular effects from inhibitor selectivity profiles. Only a small
number of kinases including CK2, MEK, and BRAF exhibited affinity
for GTP. This extensive and consistent data set of kinase-nucleotide
affinities, determined for native enzymes under defined experimental
conditions, will represent a useful resource for kinase drug discovery